NLARx In the News
State Legislators Plan 2009 Agenda, Hear From Experts Presentations
Federal Court Decision Opens Flood Gates for Data Mining Laws More
|
In the States
MASSACHUSETTS: Gift-Ban Bill Causes Another Ruckus More
Disclosure Loophole - "Let's Keep Research Payments Secret" More
Excessive Drug Prices Alleged More
NEW HAMPSHIRE: Ban on Sale of Prescribing Data Upheld More
TEXAS: State Legislators File Bills on Pricing and Gift Disclosure More
TENNESSEE: 133,000 Eligible Medicare Beneficiaries Not Enrolled in Drug Benefit More
|
Outrage of the Week
Silence! Apotex, A Doctor And Freedom Of Speech More
|
Prices and Access to Healthcare
Ovation Sued After Hiking Price of Heart Drug 1,300% More
Generic-Pill Spending Dips in 'Fierce' U.S. Price War More
Merck To Make Copycat Biotech Drugs More
With e-Prescribing, US Doctors Pick Cheaper Drugs More
Cigna Reduces Copayments for Lipitor by as Much as 50% More
AARP's Stealth Fees Often Sting Seniors With Costlier Insurance More
|
Advertising and Marketing
American Medical Student Association Launches Pharmfree.Org More
Vytorin: Public Relations Blunder More
PhRMA Announces Updated Voluntary Restrictions on DTC Advertising More
Drug Makers To Stop Some Ads More
Doctors Ditch Drug Samples to Avoid Influencing Treatment More
EU to Allow More Marketing of Prescription Drugs More
Rep. Waxman and the British Medical Journal Question New-Drug DTC More
Despite FDA Warning Website Still Connects to Acne Drug More
Penn Medicine to Disclose Doctors' Drug Ties More
Prescription Project Asks FDA To Review DTC Regs for Devices More
|
Conflicts of Interest
Baucus Health Plan Includes Disclosure of Payments to Doctors More
Wyeth's Use of Medical Ghostwriters Questioned More
Med Journals: Where Seldom Is Heard A Discouraging Word More
From Agenda Item to Published Medical Article More
Transparency Rules at the Cleveland Clinic More
AstraZeneca Ties To Nobel Foundation Questioned More |
Pharma Watch
Industry Magazine's Drug "Pipeline" Looks Like a Money Drain More
Schering-Plough Lawyer Gets $500K Reward More
Sanofi-Aventis Says Finance Chief Leaving His Post More
Where The Jobs Aren't: The Latest Layoff Tally More
Pfizer Cutting Nearly 1,000 Jobs In Europe More
Chief Of Staff Rahm Emanuel: A Friend To Pharma? More
Bristol-Myers, Biotech Firm To Develop Cancer Drugs More
Merck's Woes Illuminate the Shifts In the Drug Industry More
Big Pharma No Threat to Biotech Yet More
|
PBM Watch
Alarmed About CVS Caremark More
Report Alleges Discriminatory Practices at CVS Pharmacies More
Analyst Says Insurers Won't Take Much PBM Business More |
Data Mining
Increased Use of Electronic Health Records Spurred by Insurers More
Experian to Add Work More |
Medicare
Elderly Surprised by Medicare Fees More
Medicare Plans Criticized on Drug Pricing More
Few Seniors Benefit From Medicare Modernization Act More
Groups Criticize Extra Charges in Medicare Drug Benefit, 'Lack of Transparency' on Website More
Medicare Sign-Up time, So Read the Small Type More
|
Medicaid
States Cut Spending in Medicaid Accounts More
Governors Ask Obama for $40B for State Medicaid Programs More
Governors Call on Congress To Include Medicaid Funds in Stimulus More
CMS Issues Medicaid Rule To Give States More Flexibility More
Louisiana Lawmakers Meet To Discuss Gov's Medicaid Overhaul More
Florida's Medicaid Hotline Backlogged, Threatens Access to Care More
|
Patents and Generics
Are Patent Expirations the Answer to Improving Patient Adherence? More
Generic Drug Prices Falling in US More
Editorial: Physicians' Resistance to Use of Generics 'Discouraging' More
Pharmacies Settle Antitrust Claims With Barr More
More Biopharmas Lobby Against Biogenerics More
|
Safety and Clinical Trials
OTC Drugmakers Get Extra Year for Label Requirements More
Supreme Court May Review Whistle-Blower Case More
Study: Journal Articles on Drug Trials Offer Limited Info for Docs More
Biogen Sees New Setback For MS Drug More
Hormone Replacement Pills Linked To Breast Cancer More
HUH? Wall St. Journal Examines "Potential Harm in Providing Too Much Drug Safety Info" More
AstraZeneca Aware of Seroquel Risks in 2000, Records Show More
Asthma Inhalers May Lead to Hospitalizations, Deaths More
Asthma Drugs Too Dangerous For Kids: FDA More
FDA Panel Is Split on Risks of Some Asthma Drugs More
|
FDA Watch
FDA Commish to Resign Jan. 20 More
Baltimore's Sharfstein May Be FDA Commish? More
Sweep the FDA Clean, Stupak Says More
Q&A: Peter Rost on His Quixotic Bid to Become Obama's FDA Chief More
|
Importation and Trade
Presentations from APHA Trade and Health Forum More
European Commission Adopts Pharmaceutical Reform More
|
